A kind of traditional Chinese medicine composition for improving local circulation disorder, preparation method and application thereof
A circulatory disorder and composition technology, which is applied in the preparation of medicines for the treatment of local circulatory disorders, and the application field of traditional Chinese medicine compositions in pharmacy, can solve the problems of poor local targeting of drug treatment and unfavorable timely treatment of diseases.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] Embodiment 1 A kind of preparation of Chinese medicine composition plaster
[0021] Prescription: 267g raw Arachnium, 200g raw Aconitum, 167g clove, 167g cinnamon, 300g Angelica dahurica, 125g Asarum, 200g Chuanxiong, 125g Xu Changqing, 83g frankincense (made) , 83g myrrh (made) , 63g camphor, 63g borneol.
[0022] The preparation method of this Chinese medicine composition plaster is as follows:
[0023] Take the above-mentioned twelve raw materials, except camphor and borneol, take the ten ingredients such as Tiannanxing, dry at low temperature, pulverize into fine powder, sieve, mix evenly, and set aside. Take another 267g of rosin, 1330g of paraffin, 800g of vaseline, 233g of liquid paraffin, heat to about 100°C, melt, and when the temperature drops to 60°C, add 160g of methyl salicylate, camphor, borneol and the above-mentioned medicinal powder and mix well to prepare Make a coating, paste, cut into sections, cover the lining, slice, and make 1000 pieces, that is,...
Embodiment 2
[0024] Embodiment 2 Chinese medicine composition of the present invention is to the impact of microcirculation disorder rat
[0025] 1 Materials and methods
[0026] 1.1 Experimental animals
[0027] Healthy male SD rats, 50 males, weighing 200g±5g, were purchased from Qinglongshan Animal Breeding Farm, Jiangning District, Nanjing, certificate number: SCXK (Su) 2017-0001.
[0028] 1.2 Experimental drugs and reagents
[0029] The plaster prepared by the above-mentioned embodiment 1;
[0030] Polymer dextran: Dextran500 Sweden
[0031] 1.3 Experimental equipment
[0032] Blood Viscosity Dynamic Analyzer
[0033] 1.4 Experimental method
[0034] 50 SD rats were randomly divided into 5 groups, 10 in each group, respectively normal control group, model control group, plaster high dose group (high dose group), plaster medium dose group (middle dose group), plaster Low-dose group (low-dose group). The model group, high-dose group, and low-dose group were injected with 10% pol...
Embodiment 3
[0049] Embodiment 3 The influence of Chinese medicine composition of the present invention on arterial vasculitis obliterans
[0050] 1 Materials and methods
[0051] 1.1 General information
[0052] Nanjing Drum Tower Hospital recruited 100 patients with arterial vasculitis obliterans, and all patients participated in this study voluntarily. They will be randomly divided into control group and treatment group, with 50 people in each group. There is no statistically significant difference in general data such as gender, age, course of disease, and onset of patients between the two groups, and they are comparable. Inclusion criteria: refer to "Peripheral Vascular Diseases of Integrated Traditional Chinese and Western Medicine".
[0053] Patients diagnosed with arteriosclerotic vasculitis I and II stages; exclusion criteria: patients with severe limb infection or tissue necrosis; patients with insufficiency of important organs such as heart, liver, and kidney.
[0054] 1.2 Tr...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


